Orgalutran 0.25 mg/0.5 mL solution for injection
Sponsors
Universitair Ziekenhuis Gent, Santiago Dexeus Font Fundacio Privada, Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA
Conditions
SubfertilityWomen with infertility and low ovarian reserve.infertility
Phase 4
PPOS and CFA for elective Freeze-All ovarian stimulation cycles: a prospective cross-over study
RecruitingCTIS2023-506694-35-00
Start: 2025-01-24Target: 60Updated: 2025-04-09
A randomized comparison of one controlled ovarian stimulation with corifollitropin alfa (CFA) versus up to three modified natural cycles (MNC) in expected and established poor responders
RecruitingCTIS2023-509094-23-00
Start: 2022-07-15Target: 300Updated: 2025-04-28
The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial.
Not yet recruitingCTIS2024-514322-23-00
Target: 110Updated: 2024-09-09
Phase IV randomized, single-blind clinical trial with three parallel arms to compare ovulation triggering strategies in IVF cycles with fresh embryo transfer.
RecruitingCTIS2026-526292-37-01
Target: 126Updated: 2026-07-13